Pharmafile Logo
Pharmafocus logo
Advanced Search
remsss

Gilead facing criticism for charging $2,340 for remdesivir

June 30, 2020
Manufacturing and Production COVID-19, coronavirus

Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …

News

NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.

June 29, 2020
Sales and Marketing

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …

News
fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020
Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …

News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020
Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …

News
chinese_army

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020
Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …

News
Pfizer headquarters

Pfizer sues US for permission to help Medicare patients with rare heart conditions

June 29, 2020
Sales and Marketing Medicaid, Medicare, Pfizer

Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …

News
nhs_hispioiotror

NICE to recommend Roche cancer treatment

June 26, 2020
Medical Communications NHS, NICE

NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended …

News

Novartis agrees to pay $347 million to settle bribery allegations

June 26, 2020
Medical Communications Greece, Novartis, bribery

Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that …

News
boots

70% of BAME pharmacists in the UK have had no risk assessment for COVID-19

June 26, 2020
Medical Communications COVID-19, coronavirus

More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …

News
remdesivir_ulrich_perrey

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020
Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …

News
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

News
shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

News

NICE knocks back Novartis’ Mayzent in secondary progressive multiple sclerosis over data gaps

June 25, 2020
Sales and Marketing Mayzent, NHS, NICE, Novartis

Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment …

News
fda

New research highlights how biases play a role in FDA drug approvals

June 25, 2020
Business Services FDA, FDA Approval

A new study has highlighted how human biases affect the regulatory approval process of the FDA.

News
antibody_tests

COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020
Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …

News
fauci

NIH ordered to cancel coronavirus research funding by White House, Dr Fauci tells Congress

June 25, 2020
Business Services COVID-19, Fauci, NIH, coronavirus, pandemic

The National Institutes of Health had its funding cut from a research project into bat coronavirus, according its Director Dr …

News
shutterstock_273326141

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020
Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …

News
3806537611_b006ec40bf_c

UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown

June 24, 2020
Research and Development COVID-19, England, UK, coronavirus

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020
Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …

News
johnsons_baby_powder_massage

Johnson & Johnson loses bid to overturn baby powder cancer case

June 24, 2020
Research and Development Johnson and Johnson, talc, talc powder

Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026